Suganthiya Santhiapillai Croosu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Suganthiya Santhiapillai Croosu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Jens Brøndum Frøkjær
Department of Clinical Medicine Aalborg University Aalborg Denmark
12 shared publications - Johan Røikjer
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark
11 shared publications - Tine Maria Hansen
Department of Radiology Aalborg University Hospital Aalborg Denmark
10 shared publications - Carsten Dahl Mørch
Aalborg University
8 shared publications - Niels Ejskjaer
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark
7 shared publications Niels Ejskjaer
Department of Clinical Medicine, Aalborg University 2 , Aalborg, Denmark
4 shared publications
Latest Publications
- 11 August 2026
- Published by American Diabetes Association in Diabetes
- Vol. 75 (10) , 1881-1891
Accelerated Brain Aging in Type 1 Diabetes Across Painful and Painless Peripheral Neuropathy: MRI-Based Brain Age Estimates From Deep Learning
Structural brain alterations, including accelerated brain aging, occur in diabetes, as seen via MRI. The brain age gap (BAG) is likely caused by a combination of factors, including mechanisms associated with diabetic peripheral neuropathy (DPN) and neuropathic pain. In this study, 178 participants with type 1 diabetes (T1D) (n = 79 without DPN, 53 with painless DPN, 46 with painful DPN) and 48 healthy control individuals underwent structural brain MRI. Whole-brain and regional BAG were derived from the volBrain pipeline. Participants with T1D had an average of 3.5 years of increased BAG compared with healthy control individuals (P = 0.001). Subgroup analyses revealed increased BAG (6–7 years) for participants with DPN, regardless of the presence of pain, compared with participants with T1D without DPN and healthy control individuals (P < 0.001). Adjustment for diabetes duration attenuated group differences. Correlation analyses supported that diabetes duration was the primary driver of BAG. Sural nerve conduction velocity mediated only a 1.4-year increase in BAG. Regional effects showed a diffuse BAG distribution across the brain. These findings indicate that diabetes duration is a primary cause of accelerated brain aging in T1D, with a diffuse pattern across the brain, largely independent of painless or painful DPN. These exploratory results require validation in more rigorously characterized cohorts. Article Highlights: Accelerated brain aging has been reported in diabetes, but its links with diabetic peripheral neuropathy (DPN) and neuropathic pain remain unclear. We explored brain age gap (BAG) in type 1 diabetes to determine if it differs across neuropathic phenotypes, relates to clinical characteristics including DPN measures, and shows distinct regional patterns. Diabetes participants had 3.5 years of BAG, rising to 6–7 years in those with DPN. Diabetes duration was the main driver of BAG, whereas DPN had limited impact and neuropathic pain no clear contribution. BAG was widespread across the brain. Accelerated brain aging appears to affect people with diabetes regardless of neuropathic complications.
- 11 August 2026
- Published by American Diabetes Association in Diabetes
- Vol. 75 (10) , 1881-1891
Accelerated Brain Aging in Type 1 Diabetes Across Painful and Painless Peripheral Neuropathy: MRI-Based Brain Age Estimates From Deep Learning
Structural brain alterations, including accelerated brain aging, occur in diabetes, as seen via MRI. The brain age gap (BAG) is likely caused by a combination of factors, including mechanisms associated with diabetic peripheral neuropathy (DPN) and neuropathic pain. In this study, 178 participants with type 1 diabetes (T1D) (n = 79 without DPN, 53 with painless DPN, 46 with painful DPN) and 48 healthy control individuals underwent structural brain MRI. Whole-brain and regional BAG were derived from the volBrain pipeline. Participants with T1D had an average of 3.5 years of increased BAG compared with healthy control individuals (P = 0.001). Subgroup analyses revealed increased BAG (6–7 years) for participants with DPN, regardless of the presence of pain, compared with participants with T1D without DPN and healthy control individuals (P < 0.001). Adjustment for diabetes duration attenuated group differences. Correlation analyses supported that diabetes duration was the primary driver of BAG. Sural nerve conduction velocity mediated only a 1.4-year increase in BAG. Regional effects showed a diffuse BAG distribution across the brain. These findings indicate that diabetes duration is a primary cause of accelerated brain aging in T1D, with a diffuse pattern across the brain, largely independent of painless or painful DPN. These exploratory results require validation in more rigorously characterized cohorts. Article Highlights: Accelerated brain aging has been reported in diabetes, but its links with diabetic peripheral neuropathy (DPN) and neuropathic pain remain unclear. We explored brain age gap (BAG) in type 1 diabetes to determine if it differs across neuropathic phenotypes, relates to clinical characteristics including DPN measures, and shows distinct regional patterns. Diabetes participants had 3.5 years of BAG, rising to 6–7 years in those with DPN. Diabetes duration was the main driver of BAG, whereas DPN had limited impact and neuropathic pain no clear contribution. BAG was widespread across the brain. Accelerated brain aging appears to affect people with diabetes regardless of neuropathic complications.
- 17 November 2025
- Published by Wiley in Muscle & Nerve
- Vol. 73 (1) , 72-78
Corneal Immune Cells and Their Relation to Diabetic Peripheral Neuropathy and Neuropathic Pain
Introduction/Aims: As corneal dendritic cells (DCs) are immune cells that can reflect systemic inflammatory activity, this study aimed to investigate whether the density and maturity of corneal DCs are associated with diabetes, diabetic peripheral neuropathy (DPN), and neuropathic pain. Methods: Participants included individuals with type 1 diabetes mellitus (T1DM) and painful DPN ( n = 19), T1DM and painless DPN ( n = 15), T1DM without DPN ( n = 19), and healthy controls ( n = 20). Corneal confocal microscopy was used to quantify and categorize DCs as either mature or immature and based on their proximity to corneal nerves. Results: No significant differences between groups were observed in total DC density ( p = 0.34). Subgroup analysis revealed distinct patterns in which participants with DPN (regardless of pain status) exhibited a higher density of immature DCs distant from corneal nerves compared to those without DPN (14.4 [6.64–37.5] vs. 3.75 [0–17.7] no./mm 2 , p < 0.05). Healthy controls had a greater density of immature DCs near the nerves compared to the T1DM + DPN group (2.8 [0–8.44] vs. 8.3 [3.12–15.1] no./mm 2 ), while the T1DM + DPN group had a higher density than the painful DPN (3.1 [1.25–5.62] no./mm 2 ). For mature DCs near the nerves, individuals with painful DPN (2.5 [1.4–3.12] no./mm 2 ) had a lower density compared to all other groups. Discussion: This study demonstrates distinct patterns of corneal DC distribution in relation to painful and painless DPN. The findings suggest that immune‐mediated mechanisms may play a role in the development of neuropathy and neuropathic pain in diabetes. The pathophysiological significance remains to be clarified. Trial Registration: ClinicalTrials.gov: NCT04078516.
- 17 November 2025
- Published by Wiley in Muscle & Nerve
- Vol. 73 (1) , 72-78
Corneal Immune Cells and Their Relation to Diabetic Peripheral Neuropathy and Neuropathic Pain
Introduction/Aims: As corneal dendritic cells (DCs) are immune cells that can reflect systemic inflammatory activity, this study aimed to investigate whether the density and maturity of corneal DCs are associated with diabetes, diabetic peripheral neuropathy (DPN), and neuropathic pain. Methods: Participants included individuals with type 1 diabetes mellitus (T1DM) and painful DPN ( n = 19), T1DM and painless DPN ( n = 15), T1DM without DPN ( n = 19), and healthy controls ( n = 20). Corneal confocal microscopy was used to quantify and categorize DCs as either mature or immature and based on their proximity to corneal nerves. Results: No significant differences between groups were observed in total DC density ( p = 0.34). Subgroup analysis revealed distinct patterns in which participants with DPN (regardless of pain status) exhibited a higher density of immature DCs distant from corneal nerves compared to those without DPN (14.4 [6.64–37.5] vs. 3.75 [0–17.7] no./mm 2 , p < 0.05). Healthy controls had a greater density of immature DCs near the nerves compared to the T1DM + DPN group (2.8 [0–8.44] vs. 8.3 [3.12–15.1] no./mm 2 ), while the T1DM + DPN group had a higher density than the painful DPN (3.1 [1.25–5.62] no./mm 2 ). For mature DCs near the nerves, individuals with painful DPN (2.5 [1.4–3.12] no./mm 2 ) had a lower density compared to all other groups. Discussion: This study demonstrates distinct patterns of corneal DC distribution in relation to painful and painless DPN. The findings suggest that immune‐mediated mechanisms may play a role in the development of neuropathy and neuropathic pain in diabetes. The pathophysiological significance remains to be clarified. Trial Registration: ClinicalTrials.gov: NCT04078516.
- 13 October 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123730
Response to Letter to the Editor: Concerns about generalizability in MRI-based neuropathy classification
- 13 October 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123730
Response to Letter to the Editor: Concerns about generalizability in MRI-based neuropathy classification
- Open Access
- 16 September 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123701
Multimodal MRI analysis selecting key brain features for machine learning based classification of diabetic neuropathic pain and phenotypes
- 16 September 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123701
Open AccessMultimodal MRI analysis selecting key brain features for machine learning based classification of diabetic neuropathic pain and phenotypes
- Open Access
- 18 December 2024
- Published by Elsevier in Neuroscience
- Vol. 566, 39-48
Altered surface-based brain morphometry in type 1 diabetes and neuropathic pain
- 18 December 2024
- Published by Elsevier in Neuroscience
- Vol. 566, 39-48
Open AccessAltered surface-based brain morphometry in type 1 diabetes and neuropathic pain
- Open Access
- 20 October 2024
- Published by Elsevier in Brain Research
- Vol. 1846, 149288
Quantification of white matter hyperintensities in type 1 diabetes and its relation to neuropathy and clinical characteristics
- 20 October 2024
- Published by Elsevier in Brain Research
- Vol. 1846, 149288
Open AccessQuantification of white matter hyperintensities in type 1 diabetes and its relation to neuropathy and clinical characteristics
- Open Access
- 29 June 2023
- Published by Wiley in Muscle & Nerve
- Vol. 68 (3) , 308-315
Optimizing examination time and diagnostic performance of the histamine‐induced axon‐reflex flare response in diabetes
Introduction/Aims: The axon‐reflex flare response is a reliable method for functional assessment of small fibers in diabetic peripheral neuropathy (DPN), but broad adoption is limited by the time requirement. The aims of this study were to (1) assess diagnostic performance and optimize time required for assessing the histamine‐induced flare response and (2) associate with established parameters.Methods: A total of 60 participants with type 1 diabetes with (n = 33) or without (n = 27) DPN participated. The participants underwent quantitative sensory testing (QST), corneal confocal microscopy (CCM), and flare intensity and area size assessments by laser‐Doppler imaging (FLPI) following an epidermal skin‐prick application of histamine. The flare parameters were evaluated each minute for 15 min, and the diagnostic performance compared to QST and CCM were assessed using area under the curve (AUC). Minimum time‐requirements until differentiation and to achieve results comparable with a full examination were assessed.Results: Flare area size had better diagnostic performance compared with CCM (AUC 0.88 vs. 0.77, p < 0.01) and QST (AUC 0.91 vs. 0.81, p = 0.02) than mean flare intensity, and could distinguish people with and without DPN after 4 min compared to after 6 min (both p < 0.01). Flare area size achieved a diagnostic performance comparable to a full examination after 6 and 7 min (CCM and QST respectively, p > 0.05), while mean flare intensity achieved it after 5 and 8 min (CCM and QST respectively, p > 0.05).Discussion: The flare area size can be evaluated 6–7 min after histamine‐application, which increases diagnostic performance compared to mean flare intensity.
- 29 June 2023
- Published by Wiley in Muscle & Nerve
- Vol. 68 (3) , 308-315
Open AccessOptimizing examination time and diagnostic performance of the histamine‐induced axon‐reflex flare response in diabetes
Introduction/Aims: The axon‐reflex flare response is a reliable method for functional assessment of small fibers in diabetic peripheral neuropathy (DPN), but broad adoption is limited by the time requirement. The aims of this study were to (1) assess diagnostic performance and optimize time required for assessing the histamine‐induced flare response and (2) associate with established parameters.Methods: A total of 60 participants with type 1 diabetes with (n = 33) or without (n = 27) DPN participated. The participants underwent quantitative sensory testing (QST), corneal confocal microscopy (CCM), and flare intensity and area size assessments by laser‐Doppler imaging (FLPI) following an epidermal skin‐prick application of histamine. The flare parameters were evaluated each minute for 15 min, and the diagnostic performance compared to QST and CCM were assessed using area under the curve (AUC). Minimum time‐requirements until differentiation and to achieve results comparable with a full examination were assessed.Results: Flare area size had better diagnostic performance compared with CCM (AUC 0.88 vs. 0.77, p < 0.01) and QST (AUC 0.91 vs. 0.81, p = 0.02) than mean flare intensity, and could distinguish people with and without DPN after 4 min compared to after 6 min (both p < 0.01). Flare area size achieved a diagnostic performance comparable to a full examination after 6 and 7 min (CCM and QST respectively, p > 0.05), while mean flare intensity achieved it after 5 and 8 min (CCM and QST respectively, p > 0.05).Discussion: The flare area size can be evaluated 6–7 min after histamine‐application, which increases diagnostic performance compared to mean flare intensity.
- Open Access
- 18 April 2023
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 6 (4) , e420
Cognitive function in individuals with and without painful and painless diabetic polyneuropathy—A cross‐sectional study in type 1 diabetes
Introduction: Previous studies suggest that cognitive impairment is more prevalent in individuals with painful and painless diabetic peripheral neuropathy (DPN). However, the current evidence is not well described. This study investigated cognitive function in adults with type 1 diabetes mellitus (T1DM) and the association to painful/painless DPN and clinical parameters.Methods: This cross‐sectional, observational, case–control study included 58 participants with T1DM, sub‐grouped into 20 participants with T1DM and painful DPN, 19 participants with T1DM and painless DPN, 19 participants with T1DM without DPN, and 20 healthy controls were included. The groups were matched for sex and age. The participants performed Addenbrooke's examination III (ACE‐III), which assesses attention, memory, verbal fluency, language and visuospatial skills. Working memory was evaluated using an N‐back task. Cognitive scores were compared between the groups and correlated to age, diabetes duration, HbA1c and nerve conduction measurements.Results: Compared to healthy controls, T1DM participants showed lower total ACE‐III (p = .028), memory (p = .013) and language scores (p = .028), together with longer reaction times in the N‐back task (p = .041). Subgroup analyses demonstrated lower memory scores in those with painless DPN compared with healthy controls (p = .013). No differences were observed between the three T1DM subgroups. Cognitive scores and clinical parameters were not associated.Conclusions: This study supports the notion of cognitive alterations in T1DM and indicates that cognitive function is altered in T1DM regardless of underlying neuropathic complications. The memory domain appears altered in T1DM, particularly in those with painless DPN. Further studies are needed to verify the findings.
- 18 April 2023
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 6 (4) , e420
Open AccessCognitive function in individuals with and without painful and painless diabetic polyneuropathy—A cross‐sectional study in type 1 diabetes
Introduction: Previous studies suggest that cognitive impairment is more prevalent in individuals with painful and painless diabetic peripheral neuropathy (DPN). However, the current evidence is not well described. This study investigated cognitive function in adults with type 1 diabetes mellitus (T1DM) and the association to painful/painless DPN and clinical parameters.Methods: This cross‐sectional, observational, case–control study included 58 participants with T1DM, sub‐grouped into 20 participants with T1DM and painful DPN, 19 participants with T1DM and painless DPN, 19 participants with T1DM without DPN, and 20 healthy controls were included. The groups were matched for sex and age. The participants performed Addenbrooke's examination III (ACE‐III), which assesses attention, memory, verbal fluency, language and visuospatial skills. Working memory was evaluated using an N‐back task. Cognitive scores were compared between the groups and correlated to age, diabetes duration, HbA1c and nerve conduction measurements.Results: Compared to healthy controls, T1DM participants showed lower total ACE‐III (p = .028), memory (p = .013) and language scores (p = .028), together with longer reaction times in the N‐back task (p = .041). Subgroup analyses demonstrated lower memory scores in those with painless DPN compared with healthy controls (p = .013). No differences were observed between the three T1DM subgroups. Cognitive scores and clinical parameters were not associated.Conclusions: This study supports the notion of cognitive alterations in T1DM and indicates that cognitive function is altered in T1DM regardless of underlying neuropathic complications. The memory domain appears altered in T1DM, particularly in those with painless DPN. Further studies are needed to verify the findings.
- 7 March 2023
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (6) , 777-785
The co-existence of sensory and autonomic neuropathy in type 1 diabetes with and without pain
Aims To investigate the co-existence of diabetic peripheral neuropathy (DPN), painful diabetic peripheral neuropathy (PDPN), and cardiac autonomic neuropathy (CAN) and to establish a model to predict CAN based on peripheral measurements. Methods Eighty participants (20 type 1 diabetes (T1DM) + PDPN, 20 T1DM + DPN, 20 T1DM-DPN (without DPN), and 20 healthy controls (HC)) underwent quantitative sensory testing, cardiac autonomic reflex tests (CARTs), and conventional nerve conduction. CAN was defined as ≥ 2 abnormal CARTs. After the initial analysis, the participants with diabetes were re-grouped based on the presence or absence of small (SFN) and large fibre neuropathy (LFN), respectively. A prediction model for CAN was made using logistic regression with backward elimination. Results CAN was most prevalent in T1DM + PDPN (50%), followed by T1DM + DPN (25%) and T1DM-DPN and HC (0%). The differences in prevalence of CAN between T1DM + PDPN and T1DM-DPN/HC were significant (p < 0.001). When re-grouping, 58% had CAN in the SFN group and 55% in the LFN group, while no participants without either SFN or LFN had CAN. The prediction model had a sensitivity of 64%, a specificity of 67%, a positive predictive value of 30%, and a negative predictive value of 90%. Conclusion This study suggests that CAN predominantly co-exists with concomitant DPN.
- 7 March 2023
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (6) , 777-785
The co-existence of sensory and autonomic neuropathy in type 1 diabetes with and without pain
Aims To investigate the co-existence of diabetic peripheral neuropathy (DPN), painful diabetic peripheral neuropathy (PDPN), and cardiac autonomic neuropathy (CAN) and to establish a model to predict CAN based on peripheral measurements. Methods Eighty participants (20 type 1 diabetes (T1DM) + PDPN, 20 T1DM + DPN, 20 T1DM-DPN (without DPN), and 20 healthy controls (HC)) underwent quantitative sensory testing, cardiac autonomic reflex tests (CARTs), and conventional nerve conduction. CAN was defined as ≥ 2 abnormal CARTs. After the initial analysis, the participants with diabetes were re-grouped based on the presence or absence of small (SFN) and large fibre neuropathy (LFN), respectively. A prediction model for CAN was made using logistic regression with backward elimination. Results CAN was most prevalent in T1DM + PDPN (50%), followed by T1DM + DPN (25%) and T1DM-DPN and HC (0%). The differences in prevalence of CAN between T1DM + PDPN and T1DM-DPN/HC were significant (p < 0.001). When re-grouping, 58% had CAN in the SFN group and 55% in the LFN group, while no participants without either SFN or LFN had CAN. The prediction model had a sensitivity of 64%, a specificity of 67%, a positive predictive value of 30%, and a negative predictive value of 90%. Conclusion This study suggests that CAN predominantly co-exists with concomitant DPN.